Larimar Therapeutics (LRMR) Non-Current Assets (2013 - 2026)
Larimar Therapeutics (LRMR) recorded Non-Current Assets of $4.63 million in Q2 2026, up 4.5% from $4.43 million a year earlier.
Powered by 
Analysis
Larimar Therapeutics (LRMR) Non-Current Assets (2013 - 2026) Analysis & Trends
At the end of FY2025, Larimar Therapeutics reported Non-Current Assets of $3.82 million, down 22.4% from FY2024.
- Annual Non-Current Assets has a five-year compound annual growth rate of -10.7% (FY2020 to FY2025).
- Across earlier years, Non-Current Assets came in at $4.92 million in FY2024 (-14.6%), $5.76 million in FY2023 (+1.7%), $5.67 million in FY2022 (-12.3%) and $6.46 million in FY2021 (-4.0%).
- The Q2 2026 figure is the highest quarterly Non-Current Assets since Q1 2025.
- On a year-over-year basis, Non-Current Assets rose in two of the last seven quarters, with an average decline of 22.1%.
- Peak year-over-year performance for Non-Current Assets in the last five years was growth of 217.0% in Q1 2024, against a decline of 72.8% in Q1 2025 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 77.61 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 141.29 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 101.45 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 125.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 94.68 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 87.87 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 60.68 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 35.42 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 159.77 Bn |
| 10 | Larimar Therapeutics | 252.95 Mn | -354.12 Mn | - | 4.63 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.63 Mn |
| Dec 31, 2025 | 3.82 Mn |
| Sep 30, 2025 | 4.13 Mn |
| Jun 30, 2025 | 4.43 Mn |
| Mar 31, 2025 | 4.69 Mn |
| Dec 31, 2024 | 4.92 Mn |
| Sep 30, 2024 | 5.77 Mn |
| Jun 30, 2024 | 6.03 Mn |
| Mar 31, 2024 | 17.25 Mn |
| Dec 31, 2023 | 5.76 Mn |
| Sep 30, 2023 | 5.47 Mn |
| Jun 30, 2023 | 5.24 Mn |
| Mar 31, 2023 | 5.44 Mn |
| Dec 31, 2022 | 5.67 Mn |
| Sep 30, 2022 | 5.89 Mn |
| Jun 30, 2022 | 6.11 Mn |
| Mar 31, 2022 | 6.34 Mn |
| Dec 31, 2021 | 6.46 Mn |
| Sep 30, 2021 | 6.69 Mn |
| Jun 30, 2021 | 6.90 Mn |
API Access
Larimar Therapeutics Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=LRMR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "LRMR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=LRMR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();